2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Colorectal Neoplasms
14
Breast Neoplasms
13
Lung Neoplasms
10
Uterine Cervical Neoplasms
9
Neoplasms
8
Colonic Neoplasms
5
Hematopoietic and Lymphatic System Neoplasm
4
Prostatic Neoplasms
3
Papillomavirus Infections
3
Liver Neoplasms
3
Carcinoma, Hepatocellular
3
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Patient Compliance
2
Neoplasm Metastasis
2
Hematologic Neoplasms
2
Colorectal Cancer Screening
2
Carcinoma, Intraductal, Noninfiltrating
2
Tobacco Use
1
Smoking
1
Pyloric Stenosis, Hypertrophic
1
Psychological Well-Being
1
Overweight
1
Obesity
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma
1
Liver Diseases
1
Hypertension
1
Hepatitis C
1
Interventions
Cyclophosphamide
447
Rituximab
406
Etoposide
225
Vincristine
217
Doxorubicin
204
Filgrastim
201
Prednisone
178
Cytarabine
160
Radiotherapy
152
fludarabine phosphate
148
Methotrexate
137
Peripheral Blood Stem Cell Transplantation
130
Melphalan
128
fludarabine
116
Busulfan
101
Dexamethasone
93
Tacrolimus
76
Carmustine
74
Granulocyte Colony-Stimulating Factor
73
Mycophenolic Acid
72
Gemcitabine
66
Bortezomib
65
Antilymphocyte Serum
65
Whole-Body Irradiation
63
Bendamustine Hydrochloride
63
Lenalidomide
62
Cyclosporine
62
Ifosfamide
58
sargramostim
51
Methylprednisolone
49
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Patient Navigation
×
Clear all
NCT06063603
2025-09-18
ASCENT
Mayo Clinic
Phase NA
Completed
51 enrolled
8 charts